MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Pfizer

Închisă

SectorSănătate

25.68 -2.21

Rezumat

Modificarea prețului

24h

Curent

Minim

25.63

Maxim

26.47

Indicatori cheie

By Trading Economics

Venit

-45M

2.9B

Vânzări

938M

15B

P/E

Medie Sector

13.984

37.257

EPS

0.78

Randament dividend

6.21

Marjă de profit

19.982

Angajați

81,000

EBITDA

266M

5.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+8.6% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

6.21%

2.94%

Următoarele câștiguri

4 nov. 2025

Data viitoare de dividende

1 dec. 2025

Următoarea dată ex-dividende

7 nov. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

16B

150B

Deschiderea anterioară

27.89

Închiderea anterioară

25.68

Sentimentul știrilor

By Acuity

36%

64%

150 / 371 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Pfizer Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

1 oct. 2025, 08:54 UTC

Principalele dinamici ale pieței

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

30 sept. 2025, 15:07 UTC

Principalele dinamici ale pieței

Pfizer Shares Rise After WSJ Reports Company Will Lower Drug Costs

22 sept. 2025, 14:54 UTC

Achiziții, Fuziuni, Preluări

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- 2nd Update

22 sept. 2025, 11:51 UTC

Achiziții, Fuziuni, Preluări

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 sept. 2025, 11:09 UTC

Achiziții, Fuziuni, Preluări

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

22 sept. 2025, 10:13 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Metsera Shares Leap Premarket on Report of Takeover by Pfizer

22 sept. 2025, 07:42 UTC

Achiziții, Fuziuni, Preluări

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources

5 aug. 2025, 11:34 UTC

Câștiguri

Pfizer Boosts 2025 Adjusted EPS Outlook Following 2Q Gains

22 sept. 2025, 15:17 UTC

Achiziții, Fuziuni, Preluări

Pfizer Jumps Back into the Weight-Loss Race With $4.9B Acquisition -- Barrons.com

22 sept. 2025, 13:43 UTC

Achiziții, Fuziuni, Preluări

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 sept. 2025, 11:26 UTC

Achiziții, Fuziuni, Preluări

These Stocks Are Moving the Most Today: Fox, Coinbase, Metsera, Pfizer, Kenvue, Anywhere Real Estate, Premier, and More -- Barrons.com

22 sept. 2025, 11:26 UTC

Achiziții, Fuziuni, Preluări

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- WSJ

22 sept. 2025, 10:48 UTC

Achiziții, Fuziuni, Preluări

Pfizer: Metsera Deal Adds Four Clinical-Stage Incretin, Amylin Programs to Pipeline >PFE MTSR

22 sept. 2025, 10:47 UTC

Achiziții, Fuziuni, Preluări

Pfizer: Metsera Deal Includes Contingent Value Rights Worth Up to Additional $22.50/Share >PFE MTSR

22 sept. 2025, 10:46 UTC

Achiziții, Fuziuni, Preluări

Pfizer: Metsera Deal Has Initial Enterprise Value of $4.9 Billion >PFE MTSR

22 sept. 2025, 10:45 UTC

Achiziții, Fuziuni, Preluări

Pfizer to Pay Initial $47.50/Share for Metsera >PFE MTSR

22 sept. 2025, 10:45 UTC

Achiziții, Fuziuni, Preluări

Pfizer to Acquire Metsera and Its Next-Generation Obesity Portfolio >PFE MTSR

22 sept. 2025, 09:12 UTC

Acțiuni populare

Stocks to Watch Monday: Nippon Steel, Porsche, Infosys, Metsera -- WSJ

5 aug. 2025, 20:44 UTC

Câștiguri

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 aug. 2025, 18:20 UTC

Câștiguri

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 aug. 2025, 18:17 UTC

Câștiguri

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 aug. 2025, 16:04 UTC

Market Talk

Pfizer's New Tax Rate Helps Boost Adj EPS Outlook -- Market Talk

5 aug. 2025, 15:25 UTC

Câștiguri

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 aug. 2025, 13:56 UTC

Câștiguri

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 aug. 2025, 11:43 UTC

Câștiguri

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs. -- Barrons.com

5 aug. 2025, 11:27 UTC

Câștiguri

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 aug. 2025, 10:57 UTC

Câștiguri

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. -- Barrons.com

5 aug. 2025, 10:55 UTC

Câștiguri

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 aug. 2025, 10:53 UTC

Câștiguri

Pfizer Boosts 2025 Profit Estimate In A Sign Of 'Confidence' -- MarketWatch

5 aug. 2025, 10:51 UTC

Câștiguri

Pfizer: On Track to Deliver About $7.2B Overall Cost Savings From Cost-Improvement Initiatives b/ End of 2027 >PFE

Comparație

Modificare preț

Pfizer Așteptări

Obiectiv de preț

By TipRanks

8.6% sus

Prognoză pe 12 luni

Medie 28.53 USD  8.6%

Maxim 34 USD

Minim 24 USD

În baza a 17 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPfizer - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

17 ratings

4

Cumpărare

12

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

22.855 / 23.85Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

150 / 371 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat